Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.78 USD
0.53%
Market Closed
Updated:
May 5, 2024
Chromadex Corp
Research & Development
|
Chromadex Corp
Research & Development Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Research & Development
-$5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Research & Development
-$1.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-13%
|
|
|
Danaher Corp
NYSE:DHR
|
Research & Development
-$2.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Research & Development
-$185.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Research & Development
-$453m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Chromadex Corp's Research & Development?
Research & Development
-5m
USD
-5m
USD
Based on the financial report for Dec 31, 2023, Chromadex Corp's Research & Development amounts to -5m USD.
What is Chromadex Corp's Research & Development growth rate?
Research & Development CAGR 5Y
2%
2%
Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Chromadex Corp have been -10% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
